Qu A, Zhang S, Zou H, Li S, et al. Outcome benefits of bevacizumab biosimilar (SIBP04) combined with carboplatin and paclitaxel in advanced non-squamous non-small-cell lung cancer patients with EGFR mutation: subgroup analysis of a prospective, randomized phase III clinical trial. J Cancer Res Clin Oncol 2023 Jul 15. doi: 10.1007/s00432-023-05103.
PMID: 37452849